Autoimmune Hemolytic Anemia

Abstract

The study of Autoimmune Hemolytic Anemia had identified that this disorder has occurred due to the premature destruction of circulating the blood cell. This disease is divided into two group's warm and cold disease. The diagnosis and treatment plan of this disease was identified as this is very rare disease occurred in the age of 40 years and above the treatment of this disease has taken place in chronic prevalence of this disease in patients.

Abstract2

Introduction4

Overview of Autoimmune hemolytic anemia4

Criteria for Autoimmune hemolytic anemia5

Symptoms of Autoimmune hemolytic anemia5

Role of Epidemiology in the prevalence of this disease6

Etiology of the disease6

Diagnosis of the disease7

Treatment of the disease7

Conclusion9

Introduction

There is destruction of blood cells in autoimmune hemolytic anemia. It was identified that the immune thrombocytopenic purpura (ITP) was often seen in this disease. In this disease there are fewer roles of genetics and the destruction of sensitized blood cells had taken place in identifying this disease. It is a rare diseases and it can affect to the infant and the elderly. The majority of patients identified with this disease are of over 40 years of age (Oksenberg, 2006).

There is population based studies regarding autoimmune hemolytic anemia. AIHA is diagnosed is a very rare diseases and it is diagnosed in the laboratory. There are many improvements that have occurred in this filed. There is a slow treatment of these diseases that occurred during the prognosis. Through several investigations there are therapies that are reviewed for the treatment of this disease (Lechner, 2010).

Overview of Autoimmune hemolytic anemia

It identifies that the red blood cells destroyed before their life span is over. It looks like the whole in the centre. The role of this cell is carrying the oxygen to the body. It removes the unnecessary things from the body like carbon dioxide from the body. It's like sponge tissue in the bone. They die and their life span is about 120 days (What Is Hemolytic Anemia, 2011).

This disease is divided in to two groups ward and cold. The patients over 50 years of age the red blood cells attack and these diseases occurred in the patients. It was identified that the patients can be cured and treated when suffering from warm autoimmune hemolytic anemia disease. In the cold disease the immunoglobin M (IgM) is activated. The patient's rarely progress to rental failure in cold disease (Autoimmune Hemolytic Anemia).

Criteria for Autoimmune hemolytic anemia

There are two criteria of AIHA. They are

Evidence of hemolysis it includes the anemia plus elevated reticulocyte count in the absence of blood loss

Evidence of RBC includes autoantibodies/complement (usually indicated by a positive direct Coombs test

AIHA is dealing with infections when it usually dealing with idiopathic. This disease is common in the age of 50 and above. There is warm and cold of autoimmune hemolytic anemia is the chronic disease that deals with the chronic disorder. The treatment is compulsory for the people suffering from this chronic disease (Autoimmune Hemolytic Anemia).

Symptoms of Autoimmune hemolytic anemia

The symptoms of this ...